Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Murine-Derived"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1956
Tytuł:
Steroid-Induced Hyperglycemia and Its Effect on Outcomes of R-CHOP Chemotherapy for Diffuse Large B-Cell Lymphoma.
Autorzy:
Kristjanson M; Department of Family Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.; Urgent Cancer Care, CancerCare Manitoba, 675 McDermot Avenue, Winnipeg, MB R3E 0V9, Canada.
Lambert P; Paul Albrechtsen Research Institute CancerCare Manitoba, 675 McDermot Avenue, Winnipeg, MB R3E 0V9, Canada.; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, 675 McDermot Avenue, Winnipeg, MB R3E 0V9, Canada.
Decker KM; Paul Albrechtsen Research Institute CancerCare Manitoba, 675 McDermot Avenue, Winnipeg, MB R3E 0V9, Canada.; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, 675 McDermot Avenue, Winnipeg, MB R3E 0V9, Canada.; Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, 750 Bannatyne Avenue, Winnipeg, MB R3E 0W2, Canada.
Bruin S; Ongomiizwin Health Services Institute of Indigenous Health and Healing, 745 Bannatyne Avenue, Winnipeg, MB R3E 3N4, Canada.
Tingey E; Max Rady College of Medicine, Rady Faculty of Health Sciences 750 Bannatyne Avenue, Winnipeg, MB R3E 0W2, Canada.
Skrabek P; Department of Medical Oncology & Hematology, CancerCare Manitoba, 675 McDermot Avenue, Winnipeg, MB R3E 0V9, Canada.; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Nov 28; Vol. 30 (12), pp. 10142-10151. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Hyperglycemia*/chemically induced
Hyperglycemia*/drug therapy
Humans ; Retrospective Studies ; Antibodies, Monoclonal, Murine-Derived/adverse effects ; Prednisone/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effective clearance of rituximab-resistant tumor cells by breaking the mirror-symmetry of immunoglobulin G and simultaneous binding to CD55 and CD20.
Autorzy:
Lee SM; Department of Biomedical Sciences, Graduate School of Medicine, Korea University, 73 Goryeodae-ro, Seongbuk-gu, Seoul, 02841, Republic of Korea.; Department of Applied Chemistry, Kookmin University, 77, Jeongneung-ro, Seongbuk-gu, Seoul, 02707, Republic of Korea.
Min SW; SG Medical, 3-11, Ogeum-ro 13-gil, Songpa-gu, Seoul, 05548, Republic of Korea.
Kwon HS; SG Medical, 3-11, Ogeum-ro 13-gil, Songpa-gu, Seoul, 05548, Republic of Korea.
Bae GD; SG Medical, 3-11, Ogeum-ro 13-gil, Songpa-gu, Seoul, 05548, Republic of Korea.
Jung JH; SG Medical, 3-11, Ogeum-ro 13-gil, Songpa-gu, Seoul, 05548, Republic of Korea.
Park HI; SG Medical, 3-11, Ogeum-ro 13-gil, Songpa-gu, Seoul, 05548, Republic of Korea.
Lee SH; Department of Biomedical Sciences, Graduate School of Medicine, Korea University, 73 Goryeodae-ro, Seongbuk-gu, Seoul, 02841, Republic of Korea.
Lim CS; New Drug Development Center, Osong Medical Innovation Foundation 123, Cheongju, Chungcheongbuk-do, 28160, Republic of Korea.
Ko BJ; School of Biopharmaceutical and Medical Science, Sungshin Women's University, 55, Dobonng-Ro 76ga-gil, Gangbuk, Seoul, 01133, Republic of Korea.
Lee JC; SG Medical, 3-11, Ogeum-ro 13-gil, Songpa-gu, Seoul, 05548, Republic of Korea. .
Jung ST; Department of Biomedical Sciences, Graduate School of Medicine, Korea University, 73 Goryeodae-ro, Seongbuk-gu, Seoul, 02841, Republic of Korea. .; BK21 Graduate Program, Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea. .; Institute of Human Genetics, Korea University College of Medicine, Seoul, 02841, Republic of Korea. .; Biomedical Research Center, Korea University Anam Hospital, Seoul, 02841, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Oct 25; Vol. 13 (1), pp. 18275. Date of Electronic Publication: 2023 Oct 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Antibodies, Bispecific*/pharmacology
Humans ; Rituximab/pharmacology ; Immunoglobulin G ; Antibodies, Monoclonal, Murine-Derived/pharmacology ; Antigens, CD20 ; CD55 Antigens/metabolism ; Cell Line, Tumor ; Antibody-Dependent Cell Cytotoxicity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Usefulness of Elastin Staining to Detect Vascular Invasion in Cancer.
Autorzy:
Gonzalez J; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Bahmad HF; Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.
Ocejo S; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Abreu A; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Popp M; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Gogola S; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Fernandez V; Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.
Recine M; Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.; Department of Pathology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Poppiti R; Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.; Department of Pathology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 17; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 17.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Elastin*
Neoplasm Recurrence, Local*
Humans ; Male ; Female ; Antibodies, Monoclonal, Murine-Derived ; Neoplasm Invasiveness/pathology ; Staining and Labeling ; Biomarkers, Tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Monoclonal Antibody Targeting the HA191/199 Region of H1N1 Influenza Virus Mediates the Damage of Neural Cells.
Autorzy:
Guo CY; Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, 710068, China. .; Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Xi'an, Shaanxi, 710068, China.
Feng Q; Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, 710068, China.; Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Xi'an, Shaanxi, 710068, China.
Yan LT; Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, 710068, China.; Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Xi'an, Shaanxi, 710068, China.
Xie X; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi'an, Shaanxi, 710069, China.
Liang DY; Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, 710068, China.; Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Xi'an, Shaanxi, 710068, China.
Li Y; Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, 710068, China.; Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Xi'an, Shaanxi, 710068, China.
Feng YM; Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, 710068, China.; Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Xi'an, Shaanxi, 710068, China.
Sun LJ; Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, 710068, China. .; Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Xi'an, Shaanxi, 710068, China.
Hu J; Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, 710068, China. .; Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Xi'an, Shaanxi, 710068, China.
Pokaż więcej
Źródło:
Biochemistry. Biokhimiia [Biochemistry (Mosc)] 2021 Nov; Vol. 86 (11), pp. 1469-1476.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Monoclonal, Murine-Derived*/chemistry
Antibodies, Monoclonal, Murine-Derived*/immunology
Hemagglutinin Glycoproteins, Influenza Virus*/chemistry
Hemagglutinin Glycoproteins, Influenza Virus*/genetics
Hemagglutinin Glycoproteins, Influenza Virus*/immunology
Influenza A Virus, H1N1 Subtype*/chemistry
Influenza A Virus, H1N1 Subtype*/genetics
Influenza A Virus, H1N1 Subtype*/immunology
Molecular Dynamics Simulation*
Neurons/*metabolism
Antibodies, Viral/chemistry ; Antibodies, Viral/immunology ; Cell Line, Tumor ; Humans ; Mutagenesis, Site-Directed ; Neurons/pathology ; Protein Domains
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Maintenance regimen of GM-CSF with rituximab and lenalidomide improves survival in high-risk B-cell lymphoma by modulating natural killer cells.
Autorzy:
Sun S; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
Fulati W; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
Shen L; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
Wu M; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
Huang Z; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
Qian W; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
Chen P; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
Hu Y; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
Chen M; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
Xu Y; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
Zhang H; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
Ma J; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
Xie Y; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (12), pp. 12975-12985. Date of Electronic Publication: 2023 Apr 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Granulocyte-Macrophage Colony-Stimulating Factor*
Lymphoma, B-Cell*/drug therapy
Humans ; Aged ; Rituximab/therapeutic use ; Lenalidomide ; Prospective Studies ; Antibodies, Monoclonal, Murine-Derived ; Killer Cells, Natural ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Analysis of binding residues in monoclonal antibody with high affinity for the head domain of the rat P2X4 receptor.
Autorzy:
Igawa T; Department of Protein Structure, Function and Design, Graduate School of Pharmaceutical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan.
Kishikawa S; Department of Protein Structure, Function and Design, Graduate School of Pharmaceutical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan.
Abe Y; Department of Protein Structure, Function and Design, Graduate School of Pharmaceutical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan.; Department of Pharmaceutical Sciences, International University of Health and Welfare, Enoki-zu, Okawa Fukuoka 831-8501, Japan.
Tsuda M; Department of Life Innovation, Graduate School of Pharmaceutical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan.
Inoue K; Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan.
Ueda T; Department of Protein Structure, Function and Design, Graduate School of Pharmaceutical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan.
Pokaż więcej
Źródło:
Journal of biochemistry [J Biochem] 2021 Apr 29; Vol. 169 (4), pp. 491-496.
Typ publikacji:
Journal Article
MeSH Terms:
Antibody Affinity*
Antibodies, Monoclonal, Murine-Derived/*chemistry
Receptors, Purinergic P2X4/*chemistry
Animals ; Antibodies, Monoclonal, Murine-Derived/genetics ; Protein Domains ; Rats ; Receptors, Purinergic P2X4/genetics ; Receptors, Purinergic P2X4/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Advanced penile lymphoma: Case report and review of the literature.
Autorzy:
Arambulo S; Department of Medical Oncology, Hospital María Auxiliadora, Lima, Peru.
Calle A; Department of Medical Oncology, Hospital María Auxiliadora; Aliada Oncological Center, Lima, Peru.
Vela JM; Department of Medical Oncology, Hospital María Auxiliadora, Lima, Peru.
Sotelo MJ; Department of Medical Oncology, Hospital María Auxiliadora; Aliada Oncological Center; Oncological Research Unit, Clínica San Gabriel, Lima, Peru.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Apr-Jun; Vol. 19 (3), pp. 823-825.
Typ publikacji:
Review; Case Reports
MeSH Terms:
Lymphoma*/drug therapy
Lymphoma, Non-Hodgkin*/diagnosis
Lymphoma, Non-Hodgkin*/drug therapy
Male ; Humans ; Rituximab/therapeutic use ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Penis/surgery ; Penis/pathology
Recenzja
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Safety and tolerability of a 90-minute rapid infusion of Sandoz biosimilar rituximab in B-cell lymphoproliferative disorders in a real-world setting.
Autorzy:
Muntañola A; Department of Hematology, Hospital Universitari Mutua Terrassa, Terrassa, Spain.
Arguiñano-Pérez JM; Department of Hematology, Hospital Universitario de Navarra, Pamplona, Spain.
Dávila J; Department of Hematology, Complejo Asistencial de Ávila, Ávila, Spain.
de Villambrosia SG; Department of Hematology, Hospital Universitario Marqués de Valdecilla/IDIVAL, Santander, Spain.
Carpio C; Department of Hematology, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Jiménez-Ubieto A; Department of Hematology, Hospital 12 de Octubre, Madrid, Spain.
Salar A; Department of Hematology, Hospital del Mar, Barcelona, Spain.; Group of Applied Clinical Research in Hematology, Cancer Research Program-IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Pompeu Fabra University, Barcelona, Spain.
Pokaż więcej
Corporate Authors:
GELTAMO (Grupo español de linfomas y trasplante de médula ósea)
Źródło:
Clinical and translational science [Clin Transl Sci] 2023 Feb; Vol. 16 (2), pp. 305-312. Date of Electronic Publication: 2022 Nov 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biosimilar Pharmaceuticals*/adverse effects
Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy
Humans ; Rituximab/adverse effects ; Retrospective Studies ; Antibodies, Monoclonal, Murine-Derived/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lymphovascular invasion in early gastric cancer: impact of ancillary D2-40 and elastin staining on interobserver agreement.
Autorzy:
Takada K; Department of Pathology, Shizuoka Cancer Center, Shizuoka, Japan.; Department of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
Yoshida M; Department of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
Aizawa D; Department of Pathology, Shizuoka Cancer Center, Shizuoka, Japan.
Sato J; Department of Pathology, Shizuoka Cancer Center, Shizuoka, Japan.; Department of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
Ono H; Department of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
Sugino T; Department of Pathology, Shizuoka Cancer Center, Shizuoka, Japan.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2020 May; Vol. 76 (6), pp. 888-897. Date of Electronic Publication: 2020 May 03.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Monoclonal, Murine-Derived*
Biomarkers, Tumor/*analysis
Elastin/*metabolism
Neoplasm Invasiveness/*diagnosis
Stomach Neoplasms/*pathology
Aged ; Female ; Humans ; Lymphatic Metastasis/diagnosis ; Male ; Middle Aged ; Neoplasm Invasiveness/pathology ; Observer Variation ; Retrospective Studies ; Staining and Labeling/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The prognostic impact of monocyte fluorescence, immunosuppressive monocytes and peripheral blood immune cell numbers in HIV-associated Diffuse Large B-cell Lymphoma.
Autorzy:
Vaughan J; Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; National Health Laboratory Services, Johannesburg, South Africa.
Wiggill T; Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; National Health Laboratory Services, Johannesburg, South Africa.
Lawrie D; Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; National Health Laboratory Services, Johannesburg, South Africa.
Machaba M; Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; National Health Laboratory Services, Johannesburg, South Africa.
Patel M; Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Clinical Haematology Unit, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Jan 11; Vol. 18 (1), pp. e0280044. Date of Electronic Publication: 2023 Jan 11 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/complications
Lymphoma, Large B-Cell, Diffuse*/diagnosis
Lymphoma, Large B-Cell, Diffuse*/pathology
Monocytes*/immunology
Monocytes*/metabolism
Humans ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Leukocyte Count ; Prednisone/therapeutic use ; Prognosis ; Rituximab/therapeutic use ; South Africa/epidemiology ; Vincristine/therapeutic use ; Fluorescence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Expression of Claudin-4 and D2-40 and their significance in prostatic adenocarcinoma.
Autorzy:
Kabra H; Department of Pathology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Mohanty NR; Department of Radiology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Tripathy S; Department of Pathology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Mohanty M; Department of Pathology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Senapati U; Department of Pathology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Rath J; Department of Pathology, Hi-tech Medical College, Bhubaneswar, Odisha, India.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Jan 01; Vol. 19 (Suppl 2), pp. S800-S806. Date of Electronic Publication: 2023 Apr 30.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/pathology
Lymphatic Vessels*/chemistry
Lymphatic Vessels*/metabolism
Lymphatic Vessels*/pathology
Prostatic Neoplasms*/pathology
Humans ; Male ; Antibodies, Monoclonal, Murine-Derived/metabolism ; Biomarkers, Tumor/metabolism ; Claudin-4/genetics ; Claudin-4/metabolism ; Immunohistochemistry ; Lymphangiogenesis ; Prognosis ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Expression of TCF3 target genes defines a subclass of diffuse large B-cell lymphoma characterized by up-regulation of MYC target genes and poor clinical outcome following R-CHOP therapy.
Autorzy:
Tyryshkin K; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.; School of Computing, Queen's University, Kingston, Ontario, Canada.
Moore A; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Good D; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Popov J; Department of Internal Medicine, Queen's University, Kingston, Ontario, Canada.
Crocker S; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Rauh MJ; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Baetz T; Department of Medical Oncology, Queen's University, Kingston, Ontario, Canada.
LeBrun DP; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Jan; Vol. 64 (1), pp. 119-129. Date of Electronic Publication: 2022 Nov 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphoma, Large B-Cell, Diffuse*/diagnosis
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/genetics
Humans ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols ; Basic Helix-Loop-Helix Transcription Factors/genetics ; Cyclophosphamide/therapeutic use ; Doxorubicin/therapeutic use ; Prednisone/therapeutic use ; Prognosis ; Rituximab/therapeutic use ; Up-Regulation ; Vincristine/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development and characterization of novel anti-C5 monoclonal antibodies capable of inhibiting complement in multiple species.
Autorzy:
Zelek WM; Division of Infection and Immunity, School of Medicine, Systems Immunity Research Institute, Cardiff University, Wales, UK.
Taylor PR; Division of Infection and Immunity, School of Medicine, Systems Immunity Research Institute, Cardiff University, Wales, UK.
Morgan BP; Division of Infection and Immunity, School of Medicine, Systems Immunity Research Institute, Cardiff University, Wales, UK.
Pokaż więcej
Źródło:
Immunology [Immunology] 2019 Aug; Vol. 157 (4), pp. 283-295. Date of Electronic Publication: 2019 Jun 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Monoclonal, Murine-Derived*/immunology
Antibodies, Monoclonal, Murine-Derived*/pharmacology
Myasthenia Gravis*/drug therapy
Myasthenia Gravis*/immunology
Myasthenia Gravis*/pathology
Complement C5/*immunology
Animals ; Complement C5/antagonists & inhibitors ; Cross Reactions ; Disease Models, Animal ; Guinea Pigs ; Humans ; Mice ; Rabbits ; Rats ; Species Specificity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Generation and characterization of a monoclonal antibody against human BCL6 for immunohistochemical diagnosis.
Autorzy:
Jia K; Key Laboratory of Pathogenic Fungi and Mycotoxins of Fujian Province, School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.; Key Laboratory of Biopesticide and Chemical Biology of Education Ministry, School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.
Zhang D; Key Laboratory of Biopesticide and Chemical Biology of Education Ministry, School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.
Wang Y; Fuzhou No.1 High School, Fuzhou, China.
Liu Y; Key Laboratory of Pathogenic Fungi and Mycotoxins of Fujian Province, School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.
Kong X; Key Laboratory of Biopesticide and Chemical Biology of Education Ministry, School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.
Yang Q; Fuzhou Maixin Biotech. Co., Ltd, Fuzhou, China.
Chen H; Fuzhou Maixin Biotech. Co., Ltd, Fuzhou, China.
Xie C; Key Laboratory of Biopesticide and Chemical Biology of Education Ministry, School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.
Wang S; Key Laboratory of Pathogenic Fungi and Mycotoxins of Fujian Province, School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.; Key Laboratory of Biopesticide and Chemical Biology of Education Ministry, School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 May 07; Vol. 14 (5), pp. e0216470. Date of Electronic Publication: 2019 May 07 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Monoclonal, Murine-Derived*/chemistry
Antibodies, Monoclonal, Murine-Derived*/immunology
Immunoglobulin G*/chemistry
Immunoglobulin G*/immunology
Lymphoma, B-Cell/*diagnosis
Lymphoma, B-Cell/*immunology
Proto-Oncogene Proteins c-bcl-6/*immunology
Animals ; Enzyme-Linked Immunosorbent Assay ; Female ; Germinal Center/immunology ; Germinal Center/metabolism ; Germinal Center/pathology ; Humans ; Immunohistochemistry ; Lymphoma, B-Cell/metabolism ; Lymphoma, B-Cell/pathology ; Mice ; Mice, Inbred BALB C ; Proto-Oncogene Proteins c-bcl-6/biosynthesis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treatment of lymphoma with rituximab and chemotherapy during pregnancy.
Autorzy:
On S; Department of Pharmacy, Stanford Health Care, Palo Alto, CA, USA.
Chang A; Department of Pharmacy, Stanford Health Care, Palo Alto, CA, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (12), pp. 2897-2904. Date of Electronic Publication: 2022 Jul 20.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Lymphoma*/drug therapy
Lymphoma, Non-Hodgkin*/diagnosis
Lymphoma, Non-Hodgkin*/drug therapy
Pregnancy ; Female ; Humans ; Rituximab/adverse effects ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Infectious complications and long-term outcomes in patients with diffuse large B-Cell lymphoma and diabetes mellitus.
Autorzy:
Pasvolsky O; Institute of Hematology, Davidoff Center, Rabin Medical Center, Beilinson Hospital, Petach-Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Berger T; Institute of Hematology, Davidoff Center, Rabin Medical Center, Beilinson Hospital, Petach-Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Geiger KR; Institute of Hematology, Davidoff Center, Rabin Medical Center, Beilinson Hospital, Petach-Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Akirov A; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Institute of Endocrinology, Beilinson Hospital, Petach-Tikva, Israel.
Bshara E; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Raanani P; Institute of Hematology, Davidoff Center, Rabin Medical Center, Beilinson Hospital, Petach-Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Gafter-Gvili A; Institute of Hematology, Davidoff Center, Rabin Medical Center, Beilinson Hospital, Petach-Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Medicine A, Rabin Medical Center, Beilinson Hospital, Petach- Tikva, Israel.
Shochat T; Bio-Statistical Unit, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel.
Rozovski U; Institute of Hematology, Davidoff Center, Rabin Medical Center, Beilinson Hospital, Petach-Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Gurion R; Institute of Hematology, Davidoff Center, Rabin Medical Center, Beilinson Hospital, Petach-Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (14), pp. 3378-3384. Date of Electronic Publication: 2022 Sep 06.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus*
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Humans ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Rituximab/therapeutic use ; Doxorubicin/therapeutic use ; Prednisone/therapeutic use ; Cyclophosphamide/therapeutic use ; Vincristine/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience
Autorzy:
Özbalak M; İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Güzel Mastanzade M; İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Özlük Ö; İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Tiryaki TO; İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Erdem S; İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Özbalak EP; İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Elverdi T; İstanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Yönal Hindilerden İ; İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Altay AY; İstanbul University, İstanbul Medical Faculty, Department of Pathology, Division of Hematopathology, İstanbul, Turkey
Yeğen G; İstanbul University, İstanbul Medical Faculty, Department of Pathology, Division of Hematopathology, İstanbul, Turkey
Eşkazan AE; İstanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Ar MC; İstanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Yenerel MN; İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Soysal T; İstanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Nalçacı M; İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Ferhanoğlu B; V.K.V. American Hospital, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Kalayoğlu Beşışık S; İstanbul University, İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Pokaż więcej
Źródło:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2022 Dec 01; Vol. 39 (4), pp. 254-261. Date of Electronic Publication: 2022 Jun 03.
Typ publikacji:
Journal Article
MeSH Terms:
Biosimilar Pharmaceuticals*/adverse effects
Lymphoma, Large B-Cell, Diffuse*/pathology
Humans ; Rituximab/therapeutic use ; Prospective Studies ; Antibodies, Monoclonal, Murine-Derived/adverse effects ; Neoplasm Recurrence, Local/drug therapy ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Vincristine/adverse effects ; Cyclophosphamide/therapeutic use ; Prednisone/therapeutic use ; Doxorubicin/adverse effects ; Disease-Free Survival
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Rituximab or rituximab plus chlorambucil for translocation (11;18)-negative gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomized observational study.
Autorzy:
Lévy M; Department of Gastroenterology, AP-HP, Henri Mondor University Hospital, Créteil, France.
Dupuis J; Universite Paris Est Creteil, Creteil, France.; Lymphoid Malignancies Unit, AP-HP, Henri Mondor University Hospital, Créteil, France.
Charpy C; Department of Pathology, AP-HP, Henri Mondor University Hospital, Créteil, France.
Martin A; Department of Gastroenterology, AP-HP, Henri Mondor University Hospital, Créteil, France.
Itti E; Universite Paris Est Creteil, Creteil, France.; Department of Nuclear Medicine, AP-HP, Henri Mondor University Hospital, Créteil, France.
Sobhani I; Department of Gastroenterology, AP-HP, Henri Mondor University Hospital, Créteil, France.; Universite Paris Est Creteil, Creteil, France.
Haioun C; Universite Paris Est Creteil, Creteil, France.; Lymphoid Malignancies Unit, AP-HP, Henri Mondor University Hospital, Créteil, France.
Amiot A; Department of Gastroenterology, AP-HP, Henri Mondor University Hospital, Créteil, France.; Universite Paris Est Creteil, Creteil, France.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Nov; Vol. 63 (11), pp. 2597-2603. Date of Electronic Publication: 2022 Jun 10.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Lymphoma, B-Cell, Marginal Zone*/diagnosis
Lymphoma, B-Cell, Marginal Zone*/drug therapy
Lymphoma, B-Cell, Marginal Zone*/genetics
Humans ; Rituximab/adverse effects ; Chlorambucil/adverse effects ; Retrospective Studies ; Case-Control Studies ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Treatment Outcome ; Translocation, Genetic
SCR Disease Name:
Familial primary gastric lymphoma
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The multilobated morphology is still a better prognosis factor of diffuse large B-cell lymphoma in the R-CHOP era.
Autorzy:
Ito A; Department of Pathology, School of Medicine, Tokai University, Isehara, Kanagawa, Japan.
Miyaoka M; Department of Pathology, School of Medicine, Tokai University, Isehara, Kanagawa, Japan.
Tomita S; Department of Pathology, School of Medicine, Tokai University, Isehara, Kanagawa, Japan.
Ikoma H; Department of Pathology, School of Medicine, Tokai University, Isehara, Kanagawa, Japan.
Hiraiwa S; Department of Pathology, School of Medicine, Tokai University, Isehara, Kanagawa, Japan.
Carreras J; Department of Pathology, School of Medicine, Tokai University, Isehara, Kanagawa, Japan.
Kikuti YY; Department of Pathology, School of Medicine, Tokai University, Isehara, Kanagawa, Japan.
Kawada H; Department of Hematology and Oncology, School of Medicine, Tokai University, Isehara, Kanagawa, Japan.
Nakamura N; Department of Pathology, School of Medicine, Tokai University, Isehara, Kanagawa, Japan.
Pokaż więcej
Źródło:
Pathology international [Pathol Int] 2022 Nov; Vol. 72 (11), pp. 550-557. Date of Electronic Publication: 2022 Oct 11.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
Lymphoma, Large B-Cell, Diffuse*/pathology
Male ; Female ; Humans ; Rituximab/therapeutic use ; Vincristine/therapeutic use ; Prednisone/therapeutic use ; Retrospective Studies ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Disease-Free Survival ; Cyclophosphamide/therapeutic use ; Doxorubicin/therapeutic use ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Structure and mechanism of monoclonal antibody binding to the junctional epitope of Plasmodium falciparum circumsporozoite protein.
Autorzy:
Oyen D; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Torres JL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Aoto PC; Department of Pharmacology, University of California at San Diego, La Jolla, California, United States of America.
Flores-Garcia Y; Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Binter Š; Kymab Ltd., The Bennet Building (B930), Babraham Research Campus, Cambridge, United Kingdom.
Pholcharee T; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Carroll S; Atreca Inc., South San Francisco, California, United States of America.
Reponen S; Atreca Inc., South San Francisco, California, United States of America.
Wash R; Kymab Ltd., The Bennet Building (B930), Babraham Research Campus, Cambridge, United Kingdom.
Liang Q; Kymab Ltd., The Bennet Building (B930), Babraham Research Campus, Cambridge, United Kingdom.
Lemiale F; PATH's Malaria Vaccine Initiative, PATH Center for Vaccine Innovation and Access, Washington, United States of America.
Locke E; PATH's Malaria Vaccine Initiative, PATH Center for Vaccine Innovation and Access, Washington, United States of America.
Bradley A; Kymab Ltd., The Bennet Building (B930), Babraham Research Campus, Cambridge, United Kingdom.; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
King CR; PATH's Malaria Vaccine Initiative, PATH Center for Vaccine Innovation and Access, Washington, United States of America.
Emerling D; Atreca Inc., South San Francisco, California, United States of America.
Kellam P; Kymab Ltd., The Bennet Building (B930), Babraham Research Campus, Cambridge, United Kingdom.; Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom.
Zavala F; Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Wilson IA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2020 Mar 09; Vol. 16 (3), pp. e1008373. Date of Electronic Publication: 2020 Mar 09 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Binding Sites, Antibody*
Antibodies, Monoclonal, Murine-Derived/*chemistry
Antibodies, Protozoan/*chemistry
Epitopes/*chemistry
Plasmodium falciparum/*chemistry
Protozoan Proteins/*chemistry
Animals ; Antibodies, Monoclonal, Murine-Derived/immunology ; Antibodies, Protozoan/immunology ; Epitopes/immunology ; Female ; Male ; Mice ; Mice, Transgenic ; Plasmodium falciparum/immunology ; Protozoan Proteins/immunology ; Structure-Activity Relationship
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 1956

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies